However, the tumor-initiation ability of α2δ1+ cells is the highest among these population (Fig. 3F, Supplementary Table 5), indicating that α2δ1 is the most robust marker for enriching NSCLC TICs compared with CD133 and CD166. This evidence concerns the gene ALCAM and neoplasm.